Free Trial

Lixte Biotechnology (LIXT) SEC Filings & 10K Form

$2.39
+0.05 (+2.14%)
(As of 07/24/2024 ET)

Recent Lixte Biotechnology SEC Filings

DateFilerForm TypeView
07/11/2024
12:55 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2024
3:16 PM
Bernards Rene (Reporting)
Lixte Biotechnology (Issuer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
5:22 PM
Brown Regina (Reporting)
Lixte Biotechnology (Issuer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
5:24 PM
Forman Stephen J. (Reporting)
Lixte Biotechnology (Issuer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
5:27 PM
Lixte Biotechnology (Issuer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer)
Yen Yun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
1:47 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
7:30 AM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
4:29 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
4:05 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
11:00 AM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:30 AM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2024
11:15 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form EFFECT
04/30/2024
4:07 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form S-3/A
04/23/2024
12:46 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/22/2024
10:17 AM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:30 AM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2024
9:48 AM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
4:21 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
1:28 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
4:16 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2023
4:27 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
1:51 PM
Lixte Biotechnology (Issuer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer)
van der Baan Bastiaan Jeroen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
2:47 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form DEF 14A
10/10/2023
2:55 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form DEFA14A
10/05/2023
7:36 PM
Lixte Biotechnology (Issuer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer)
van der Baan Bastiaan Jeroen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
7:39 PM
Bernards Rene (Reporting)
Lixte Biotechnology (Issuer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer)
Form 4/A
10/04/2023
8:05 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
5:10 PM
Bernards Rene (Reporting)
Lixte Biotechnology (Issuer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
3:05 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form PRE 14A
09/27/2023
5:05 AM
Lixte Biotechnology (Issuer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer)
van der Baan Bastiaan Jeroen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
5:15 AM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2023
10:20 AM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2023
11:15 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form EFFECT
08/09/2023
7:30 AM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2023
2:37 PM
Lixte Biotechnology (Filer)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer)
Form D
Notice of Exempt Offering of Securities 
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:LIXT) was last updated on 7/25/2024 by MarketBeat.com Staff

From Our Partners